Networked: 32 relevant articles (0 outcomes, 5 trials/studies)

Bio-Agent Context: Research Results


1. Doshi, Shrenik: 1 article (01/2015)
2. Bhargava, Balram: 1 article (01/2015)
3. Salahuddin, Salman: 1 article (01/2015)
4. Ramakrishnan, Lakshmy: 1 article (01/2015)
5. Singh, Sandeep: 1 article (01/2015)
6. Tarik, Mohamad: 1 article (01/2015)
7. Karthikeyan, Ganesan: 1 article (01/2015)
8. Ramakrishnan, Sivasubramanian: 1 article (01/2015)
9. Bahl, Vinay K: 1 article (01/2015)
10. Barwad, Parag: 1 article (01/2015)

Related Diseases

1. Myocardial Infarction
01/01/1993 - "Antistreptokinase antibody and neutralization titres (NT) were measured in three groups of patients to determine if this practice is appropriate: 1. (early)--36 patients whose titres were measured for at least 5 days after thrombolysis; 2. (late)--57 patients who received thrombolysis 12-54 months previously; 3. (controls)--182 consecutive suspected myocardial infarction patients (without previous exposure to thrombolysis). "
11/15/1996 - "To investigate why approximately one third of patients thrombolysed with streptokinase fail to reperfuse, we assessed the lytic status, antistreptokinase antibody and non invasive parameters of reperfusion in 95 consecutive patients with acute myocardial infarction treated with streptokinase for the first time. "
06/01/2005 - "The objective of the study is to determine if the presence of antistreptokinase (ASK) antibody in the blood, leads to ineffective thrombolytic therapy with streptokinase (SK) in acute myocardial infarction (AMI) and to investigate if increased dose of streptokinase (2.5 million units) could improve the infarct-related artery (IRA) patency or the clinical outcome in these patients. "
06/01/2005 - "Effect of pretreatment antistreptokinase antibody and streptococcal infection on the efficacy and dosage of streptokinase in acute myocardial infarction."
11/01/1999 - "Antistreptokinase IgG (antiSK IgG) from blood of 8 patients with acute myocardial infarction that were treated by streptokinase (SK) has been investigated. "
2. Streptococcal Infections (Streptococcal Infection)
3. Rheumatic Fever (Acute Articular Rheumatism)
4. Rheumatic Heart Disease (Rheumatic Heart Diseases)
5. Rheumatoid Arthritis

Related Drugs and Biologics

1. Streptokinase
2. Antistreptolysin (Antistreptolysin O)
3. Anistreplase (APSAC)
4. Immunoglobulin G (IgG)
5. Deoxyribonuclease I (Nickase)
6. Immunoglobulins (Immunoglobulin)
7. gamma-Globulins (gamma-Globulin)
8. Antibodies
9. Streptodornase and Streptokinase
10. Plasminogen Activators (Plasminogen Activator)

Related Therapies and Procedures

1. Thrombolytic Therapy
2. Rectal Administration